Companies House · OC415849

MEDAC PHARMA LLP

UK registered company, limited liability partnership, incorporated 9 Feb 2017.

Active
50
Public contracts
0
Spend payments
Total spend

MEDAC PHARMA LLP is a UK company registered at Companies House under number OC415849. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
OC415849
Status
Active
Company type
Limited Liability Partnership
Incorporated
9 Feb 2017
Country of origin
United Kingdom
Registered office
2 LEMAN STREET, LONDON, E1W 9US, UNITED KINGDOM
Nature of business (SIC)
None Supplied
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to MEDAC PHARMA LLP.

ProcurementBuyerAwardedValue
Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP47924 Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Generic Drugs - Injections/InfusionsVelindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts
Generic Drugs - Topicals & MiscellaneousVelindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals - 1 May 2023NHS England
NHS National Pharmaceuticals Transition 2023_1NHS England
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
NHS National Generic Pharmaceuticals Transition 2021_1The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Transition 2021_1The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Transition 2021_1The NHS Commissioning Board (operating under the name of NHS England)
Generic Injections/Infusions 4Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (On Behalf of all Wales) Health Boards
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals Transition 2022_1NHS England
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS National Pharmaceuticals Transition 2021_3The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Interim 2 2020The NHS Commissioning Board (operating under the name of NHS England)
Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NHS National Branded Interim - 1 June 2026NHS England9 Apr 2026£529.1m

Supplier identities

How this company appears as a supplier across the data.

FAQs about MEDAC PHARMA LLP

Is MEDAC PHARMA LLP an active company?

MEDAC PHARMA LLP (company number OC415849) is recorded as "Active", incorporated on 9 Feb 2017.

What does MEDAC PHARMA LLP do?

Its Companies House nature-of-business (SIC) is: None Supplied.

Has MEDAC PHARMA LLP won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is MEDAC PHARMA LLP based?

Its registered office is 2 LEMAN STREET, LONDON, E1W 9US, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable